The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395

Effects of stress throughout the lifespan on the brain, behaviour and cognition

Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2639 · Cited by 6,256

Stress and the brain: from adaptation to disease

de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders

Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 1×

The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission

Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393

Effects of early life stress on cognitive and affective function: an integrated review of human literature

Pechtel, P., & Pizzagalli, D. A. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2009-2 · Cited by 1,352

Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates

Dalley, J. W., Cardinal, R. N., & Robbins, T. W. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.09.006 · Cited by 1,329

The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., Connor, R., Davis, S., Deakin, B., DeRubeis, R. J., et al. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3628 · Cited by 1,292

Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain

Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263

Social influences on neuroplasticity: stress and interventions to promote well-being

Davidson, R. J., & McEwen, B. S. (2012) · Nature Neuroscience · doi:10.1038/nn.3093 · Cited by 892

The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

Hilmas, C., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R., & Albuquerque, E. X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 859

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid

Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849

Endogenous kynurenines as targets for drug discovery and development

Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768

Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751

Modafinil: a review of neurochemical actions and effects on cognition

Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713

Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35

Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 687

Chronic stress, cognitive functioning and mental health

Marin, M.-F., Lord, C., Andrews, J., Juster, R.-P., Sindi, S., Arsenault-Lapierre, G., Fiocco, A. J., & Lupien, S. J. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.02.016 · Cited by 654

Kynurenic Acid Is a Potent Endogenous Aryl Hydrocarbon Receptor Ligand that Synergistically Induces Interleukin-6 in the Presence of Inflammatory Signaling

DiNatale, B. C., Murray, I. A., Schroeder, J. C., Flaveny, C. A., Lahoti, T. S., Laurenzana, E. M., Omiecinski, C. J., & Perdew, G. H. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq024 · Cited by 634

CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression

Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630

Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis

Newcomer, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00067-0 · Cited by 604

Increased cortical kynurenate content in schizophrenia

Schwarcz, R., Rassoulpour, A., Wu, H.-Q., Medoff, D., Tamminga, C. A., & Roberts, R. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01078-2 · Cited by 590

Quinolinic acid in cerebrospinal fluid and serum in HIV‐1 Infection: Relationship to clinical and neurological status

Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290215 · Cited by 571

Repeated Stress Causes Cognitive Impairment by Suppressing Glutamate Receptor Expression and Function in Prefrontal Cortex

Yuen, E. Y., Wei, J., Liu, W., Zhong, P., Li, X., & Yan, Z. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.033 · Cited by 558

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism

Neill, J. C., Barnes, S., Cook, S., Grayson, B., Idris, N. F., McLean, S. L., Snigdha, S., Rajagopal, L., & Harte, M. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.004 · Cited by 530

Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guérin

O'Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 502

Chronic quinolinic acid lesions in rats closely resemble Huntington's disease

Beal, M., Ferrante, R., Swartz, K., & Kowall, N. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01649.1991 · Cited by 499

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

Wang, Y., Liu, H., McKenzie, G., Witting, P. K., Stasch, J.-P., Hahn, M., Changsirivathanathamrong, D., Wu, B. J., Ball, H. J., Thomas, S. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2092 · Cited by 446

Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia

Phillips, W. A., & Silverstein, S. M. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03000025 · Cited by 445

α7 Nicotinic Receptor Transduces Signals to Phosphatidylinositol 3-Kinase to Block A β-Amyloid-induced Neurotoxicity

Kihara, T., Shimohama, S., Sawada, H., Honda, K., Nakamizo, T., Shibasaki, H., Kume, T., & Akaike, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008035200 · Cited by 415

Linking cognitive aging to alterations in dopamine neurotransmitter functioning: Recent data and future avenues

Bäckman, L., Lindenberger, U., Li, S.-C., & Nyberg, L. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.008 · Cited by 414

Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia

Breese, C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00121-4 · Cited by 345

An expanding range of targets for kynurenine metabolites of tryptophan

Stone, T. W., Stoy, N., & Darlington, L. G. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.09.006 · Cited by 344

Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease

Tadaiesky, M. T., Dombrowski, P. A., Figueiredo, C. P., Cargnin-Ferreira, E., Da Cunha, C., & Takahashi, R. N. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.035 · Cited by 343

Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus

Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C., & Muchowski, P. J. (2005) · Nature Genetics · doi:10.1038/ng1542 · Cited by 328

Tryptophan metabolism and oxidative stress in patients with Huntington's disease

Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., & Darlington, L. G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 310

Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease

Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301

Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge

Salazar, A., Gonzalez-Rivera, B. L., Redus, L., Parrott, J. M., & O'Connor, J. C. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.03.010 · Cited by 263

The Excitotoxin Quinolinic Acid Induces Tau Phosphorylation in Human Neurons

Rahman, A., Ting, K., Cullen, K. M., Braidy, N., Brew, B. J., & Guillemin, G. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006344 · Cited by 257

Presynaptic kynurenate‐sensitive receptors inhibit glutamate release

Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia

Sathyasaikumar, K. V., Stachowski, E. K., Wonodi, I., Roberts, R. C., Rassoulpour, A., McMahon, R. P., & Schwarcz, R. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq112 · Cited by 253

Cognitive functions and corticostriatal circuits: insights from Huntington's disease

Lawrence, A. D., Sahakian, B. J., & Robbins, T. W. (1998) · Trends in Cognitive Sciences · doi:10.1016/s1364-6613(98)01231-5 · Cited by 252

Influenza Infection Induces Neuroinflammation, Alters Hippocampal Neuron Morphology, and Impairs Cognition in Adult Mice

Jurgens, H. A., Amancherla, K., & Johnson, R. W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6389-11.2012 · Cited by 243

NMDA receptor regulation of memory and behavior in humans

Newcomer, J. W., & Krystal, J. H. (2001) · Hippocampus · doi:10.1002/hipo.1069 · Cited by 241

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

Nilsson, L. K., Linderholm, K. R., Engberg, G., Paulson, L., Blennow, K., Lindström, L. H., Nordin, C., Karanti, A., Persson, P., & Erhardt, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.013 · Cited by 238

Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs

Cochran, S. M., Kennedy, M., McKerchar, C. E., Steward, L. J., Pratt, J. A., & Morris, B. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300031 · Cited by 236

The cholinergic system and spatial learning

Deiana, S., Platt, B., & Riedel, G. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.036 · Cited by 232

Reduction of Endogenous Kynurenic Acid Formation Enhances Extracellular Glutamate, Hippocampal Plasticity, and Cognitive Behavior

Potter, M. C., Elmer, G. I., Bergeron, R., Albuquerque, E. X., Guidetti, P., Wu, H.-Q., & Schwarcz, R. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.39 · Cited by 228

Elevations of Endogenous Kynurenic Acid Produce Spatial Working Memory Deficits

Chess, A. C., Simoni, M. K., Alling, T. E., & Bucci, D. J. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl033 · Cited by 225

Synthesis and Biochemical Evaluation of N-(4-Phenylthiazol-2-yl)benzenesulfonamides as High-Affinity Inhibitors of Kynurenine 3-Hydroxylase

Röver, S., Cesura, A. M., Huguenin, P., Kettler, R., & Szente, A. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970467t · Cited by 211

Loss of α7 Nicotinic Receptors Enhances β-Amyloid Oligomer Accumulation, Exacerbating Early-Stage Cognitive Decline and Septohippocampal Pathology in a Mouse Model of Alzheimer's Disease

Hernandez, C. M., Kayed, R., Zheng, H., Sweatt, J. D., & Dineley, K. T. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5038-09.2010 · Cited by 204 · cited 1×

Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

Saito, K., Markey, S. P., & Heyes, M. P. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90467-g · Cited by 199

NMDA Receptors and Learning and Memory Processes

Castellano, C., Cestari, V., & Ciamei, A. (2001) · Current Drug Targets · doi:10.2174/1389450013348515 · Cited by 197

Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits

Lawrence, A. D. (2000) · Brain · doi:10.1093/brain/123.7.1349 · Cited by 191

3-Hydroxyanthranilate oxygenase activity is increased in the brains of Huntington disease victims.

Schwarcz, R., Okuno, E., White, R. J., Bird, E. D., & Whetsell, W. O. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4079 · Cited by 184

3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum

Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180

Gene expression changes by amyloid β peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes

Walker, D. G., Link, J., Lue, L.-F., Dalsing-Hernandez, J. E., & Boyes, B. E. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705377 · Cited by 180

Endogenous kynurenic acid disrupts prepulse inhibition

Erhardt, S., Schwieler, L., Emanuelsson, C., & Geyer, M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.006 · Cited by 178

Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease

Schwarcz, R., Guidetti, P., Sathyasaikumar, K. V., & Muchowski, P. J. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.005 · Cited by 176

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

Rassoulpour, A., Wu, H., Ferrė, S., & Schwarcz, R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03134.x · Cited by 174

Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes

Guillemin, G. J., Croitoru‐Lamoury, J., Dormont, D., Armati, P. J., & Brew, B. J. (2003) · Glia · doi:10.1002/glia.10175 · Cited by 173

Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice

Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E. J., Wheeler, V. C., Woodman, B., & Schwarcz, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166

Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes

Wonodi, I., Stine, O. C., Sathyasaikumar, K. V., Roberts, R. C., Mitchell, B. D., Hong, L. E., Kajii, Y., Thaker, G. K., & Schwarcz, R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.71 · Cited by 166

Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease

Ting, K. K., Brew, B. J., & Guillemin, G. J. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-36 · Cited by 166

Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

Pocivavsek, A., Wu, H.-Q., Potter, M. C., Elmer, G. I., Pellicciari, R., & Schwarcz, R. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.127 · Cited by 165

Altered kynurenine metabolism correlates with infarct volume in stroke

Darlington, L. G., Mackay, G. M., Forrest, C. M., Stoy, N., George, C., & Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05838.x · Cited by 160

Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

Carpenedo, R., Chiarugi, A., Russi, P., Lombardi, G., Carlà, V., Pellicciari, R., Mattoli, L., & Moroni, F. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90227-5 · Cited by 159

Kynurenine Hydroxylase Inhibitors Reduce Ischemic Brain Damage: Studies with (m-Nitrobenzoyl)-Alanine (mNBA) and 3,4-Dimethoxy-[-N-4-(Nitrophenyl)Thiazol-2YL]-Benzenesulfonamide (Ro 61-8048) in Models of Focal or Global Brain Ischemia

Cozzi, A., Carpenedo, R., & Moroni, F. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00007 · Cited by 159

Progress Towards Validating the NMDA Receptor Hypofunction Hypothesis of Schizophrenia

Lindsley, C. W., Shipe, W. D., Wolkenberg, S. E., Theberge, C. R., Williams, D., Jr., Sur, C., & Kinney, G. G. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777057599 · Cited by 156

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

Pearson, S. J., & Reynolds, G. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90749-w · Cited by 155

Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

Alexander, K., Wu, H., Schwarcz, R. M., & Bruno, J. P. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2539-2 · Cited by 149

On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio

Darlington, L., Forrest, C., Mackay, G. M., Smith, R. A., Smith, A. J., Stoy, N., & Stone, T. W. (2010) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s4282 · Cited by 146

Indoleamine 2,3-dioxygenase activity in nonagenarians is markedly increased and predicts mortality

Pertovaara, M., Raitala, A., Lehtimäki, T. J., Karhunen, P. J., Oja, S. S., Jylhä, M. K., Hervonen, A., & Hurme, M. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2006.01.020 · Cited by 139

Modulation of the Kynurenine Pathway in Search for New Neuroprotective Agents.Synthesis and Preliminary Evaluation of (m-Nitrobenzoyl)alanine, a Potent Inhibitor of Kynurenine-3-hydroxylase

Pellicciari, R., Natalini, B., Costantino, G., Mahmoud, M. R., Mattoli, L., Sadeghpour, B. M., Moroni, F., Chiarugi, A., & Carpenedo, R. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a015 · Cited by 139

Neuroprotective Effects of L-Kynurenine on Hypoxia—Ischemia and NMDA Lesions in Neonatal Rats

Nozaki, K., & Beal, M. F. (1992) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1992.57 · Cited by 136

Early-life stress and cognitive outcome

Hedges, D. W., & Woon, F. L. M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2090-6 · Cited by 135

Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease

Sapko, M. T., Guidetti, P., Yü, P., Tagle, D. A., Pellicciari, R., & Schwarcz, R. M. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.004 · Cited by 134

Targeted Deletion of the Kynurenine Aminotransferase II Gene Reveals a Critical Role of Endogenous Kynurenic Acid in the Regulation of Synaptic Transmission viaα7 Nicotinic Receptors in the Hippocampus

Alkondon, M., Pereira, E. F. R., Yü, P., Arruda, E. Z., Almeida, L. E. F., Guidetti, P., Fawcett, W. P., Sapko, M. T., Randall, W. R., Schwarcz, R. M., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5631-03.2004 · Cited by 134

Forebrain NR2B Overexpression Facilitating the Prefrontal Cortex Long-Term Potentiation and Enhancing Working Memory Function in Mice

Cui, Y., Jin, J., Zhang, X., Xu, H., Yang, L., Du, D., Zeng, Q., Tsien, J. Z., Yu, H., & Cao, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020312 · Cited by 134

In VivoEvidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington DiseasePreprint

Heng, M. Y., Detloff, P. J., Wang, P. L., Tsien, J. Z., & Albin, R. L. (2008) · Nature Precedings · doi:10.1523/jneurosci.5599-08.2009 · Cited by 131

Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release

Zmarowski, A., Wu, H., Brooks, J. M., Potter, M., Pellicciari, R., Schwarcz, R., & Bruno, J. P. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06594.x · Cited by 129

Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease

Bonda, D., Mailankot, M., Stone, J. G., Garrett, M. R., Staniszewska, M. M., Castellani, R. J., Siedlak, S. L., Zhu, X., Lee, H., Perry, G. L., et al. (2010) · Redox Report · doi:10.1179/174329210x12650506623645 · Cited by 127

Psychological Stress-Induced, IDO1-Dependent Tryptophan Catabolism: Implications on Immunosuppression in Mice and Humans

Kiank, C., Zeden, J.-P., Drude, S., Domańska, G., Fusch, G., Otten, W., & Schuett, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011825 · Cited by 127

Stressful Life Events, Chronic Difficulties, and the Symptoms of Clinical Depression

Muscatell, K. A., Slavich, G. M., Monroe, S. M., & Gotlib, I. H. (2009) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e318199f77b · Cited by 126

Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients

Myint, A.-M., Schwarz, M., Verkerk, R. M., Mueller, H. H., Zach, J., Scharpé, S., Steinbusch, H. W. M., Leonard, B. E., & Kim, Y. K. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.005 · Cited by 116

Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington's disease

Shear, D. A., Dong, J., Gundy, C. D., Haik-Creguer, K. L., & Dunbar, G. L. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00070-0 · Cited by 116

L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning

Chess, A. C., Landers, A., & Bucci, D. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.013 · Cited by 114

Kynurenine pathway metabolism in human blood–brain–barrier cells: implications for immune tolerance & neurotoxicity

Owe‐Young, R., Webster, N. L., Mukhtār, M., Pomerantz, R. J., Smythe, G. A., Walker, D. W., Armati, P. J., Crowe, S. M., & Brew, B. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05241.x · Cited by 112

Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings

Graef, S., Schönknecht, P., Sabri, O., & Hegerl, U. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2153-8 · Cited by 111

High-affinity uptake of L-kynurenine by a Na+-independent transporter of neutral amino acids in astrocytes

Speciale, C., Hares, K., Schwarcz, R. M., & Brookes, N. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-06-02066.1989 · Cited by 110

Pre‐ and postnatal exposure to kynurenine causes cognitive deficits in adulthood

Pocivavsek, A., Wu, H., Elmer, G. I., Bruno, J. P., & Schwarcz, R. M. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08064.x · Cited by 109

Kynurenic acid blocks nicotinic synaptic transmission to hippocampal interneurons in young rats

Stone, T. W. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05540.x · Cited by 106

Uptake of Kynurenine into Rat Brain Slices

Speciale, C., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13296.x · Cited by 106

Comparison of the Neurochemical and Behavioral Effects Resulting from the Inhibition of Kynurenine Hydroxylase and/or Kynureninase

Chiarugi, A., Carpenedo, R., Molina, M. T., Mattoli, L., Pellicciari, R., & Moroni, F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031176.x · Cited by 105

The NMDA Agonist D-Cycloserine Facilitates Fear Memory Consolidation in Humans

Kalisch, R., Holt, B., Petrović, P., Martino, B. D., Klöppel, S., Büchel, C., & Dolan, R. J. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn076 · Cited by 104

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum

Amori, L., Wu, H., Marinozzi, M., Pellicciari, R., Guidetti, P., & Schwarcz, R. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.055 · Cited by 101

Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers

Mexal, S., Berger, R., Logel, J., Ross, R. G., Freedman, R., & Leonard, S. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9233-4 · Cited by 101

Abnormal Neurotransmitter Release Underlying Behavioral and Cognitive Disorders: Toward Concepts of Dynamic and Function-Specific Dysregulation

Sarter, M., Bruno, J. P., & Parikh, V. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301285 · Cited by 100

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment

Gold, A. B., Herrmann, N., Swardfager, W., Black, S. E., Aviv, R. I., Tennen, G., Kiss, A., & Lanctôt, K. L. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-17 · Cited by 98

Early kynurenergic impairment in Huntington's Disease and in a transgenic animal model

Guidetti, P., Reddy, P. H., Tagle, D. A., & Schwarcz, R. M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00956-3 · Cited by 97

The N-Methyl-D-Aspartate Receptor Co-agonist D-Cycloserine Facilitates Declarative Learning and Hippocampal Activity in Humans

Onur, O. A., Schlaepfer, T. E., Kukolja, J., Bauer, A., Jeung, H., Patin, A., Otte, D.-M., Shah, N. J., Maier, W., Kendrick, K. M., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.01.022 · Cited by 97

Prolonged Survival of a Murine Model of Cerebral Malaria by Kynurenine Pathway Inhibition

Clark, C. J., Mackay, G., Smythe, G. A., Bustamante, S., Stone, T. W., & PHILLIPS, R. S. (2005) · Infection and Immunity · doi:10.1128/iai.73.8.5249-5251.2005 · Cited by 96

Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia

Dounay, A. B., Anderson, M. D., Bechle, B. M., Campbell, B. M., Claffey, M. M., Evdokimov, A. G., Evrard, E., Fonseca, K. R., Gan, X., Ghosh, S., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200204m · Cited by 89

Kynurenine Disposition in Blood and Brain of Mice: Effects of Selective Inhibitors of Kynurenine Hydroxylase and of Kynureninase

Chiarugi, A., Carpenedo, R., & Moroni, F. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020692.x · Cited by 84

Blood levels of kynurenines, interleukin‐23 and soluble human leucocyte antigen‐G at different stages of Huntington’s disease

Forrest, C., Mackay, G. M., Stoy, N., Spiden, S. L., Taylor, R., Stone, T. W., & Darlington, L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06442.x · Cited by 83

Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls

Holtze, M., Saetre, P., Engberg, G., Schwieler, L., Werge, T. M., Andreassen, O. A., Hall, H., Terenius, L. Y., Agartz, I., Jönsson, E. G., et al. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100175 · Cited by 80

Increased concentration of cerebral kynurenic acid alters stimulus processing and conditioned responding

Chess, A. C., & Bucci, D. J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.03.006 · Cited by 78

Modulators of the Kynurenine Pathway of Tryptophan Metabolism: Synthesis and Preliminary Biological Evaluation of ( S )‐4‐(Ethylsulfonyl)benzoylalanine, a Potent and Selective Kynurenine Aminotransferase II (KAT II) Inhibitor

Pellicciari, R., Rizzo, R. C., Costantino, G., Marinozzi, M., Amori, L., Guidetti, P., Wu, H., & Schwarcz, R. M. (2006) · ChemMedChem · doi:10.1002/cmdc.200500095 · Cited by 78

Prenatal inhibition of the tryptophan–kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus

Forrest, C. M., Khalil, O. S., Pisar, M., Darlington, L. G., & Stone, T. W. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.031 · Cited by 77

Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels

Mok, M. H. S., Fricker, A.-C., Weil, A., & Kew, J. N. C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.003 · Cited by 74

Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring

Forrest, C. M., Khalil, O. S., Pisar, M., Smith, R. A., Darlington, L. G., & Stone, T. W. (2012) · Molecular Brain · doi:10.1186/1756-6606-5-22 · Cited by 73

Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain

Ceresoli‐Borroni, G., Rassoulpour, A., Wu, H., Guidetti, P., & Schwarcz, R. M. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0432-z · Cited by 72

Dysfunctional kynurenine pathway metabolism in the R6/2 mouse model of Huntington’s disease

Sathyasaikumar, K. V., Stachowski, E. K., Amori, L., Guidetti, P., Muchowski, P. J., & Schwarcz, R. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06675.x · Cited by 71

Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis

Rodgers, J., Stone, T. W., Barrett, M. P., Bradley, B., & Kennedy, P. G. E. (2009) · Brain · doi:10.1093/brain/awp074 · Cited by 69

Acute psychotic symptoms in HIV-1 infected patients are associated with increased levels of kynurenic acid in cerebrospinal fluid.

Atlas, A., Gisslén, M., Nordin, C., Lindström, L., & Schwieler, L. (2007) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2006.02.005 · Cited by 63

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia

Gellért, L., Fuzik, J., Göblös, A., Sárközi, K., Marosi, M., Kis, Z., Farkas, T., Szatmári, I., Fülöp, F., Vécsei, L., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.05.069 · Cited by 63

Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons

Nilsson, L. K., Linderholm, K. R., & Erhardt, S. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0343-z · Cited by 63

Cognitive Manifestations of Huntington Disease in Relation to Genetic Structure and Clinical Onset

Jason, G. W., Suchowersky, O., Pajurkova, E. M., Graham, L. M., Klimek, M. L., Garber, A. T., & Poirier-Heine, D. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210019008 · Cited by 61

1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats

Luchowski, P., Luchowska, E., Turski, W. A., & Urbańska, E. M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00735-8 · Cited by 59

Proinflammatory cytokine interferon‐γ increases induction of indoleamine 2,3‐dioxygenase in monocytic cells primed with amyloid β peptide 1–42: implications for the pathogenesis of Alzheimer’s disease

Yamada, A., Akimoto, H., Kagawa, S., Guillemin, G. J., & Takikawa, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06175.x · Cited by 58

The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders

Kandanearatchi, A., & Brew, B. J. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08500.x · Cited by 56

The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.

Miller, J. M., Macgarvey, U., & Beal, M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90186-b · Cited by 53

Involvement of kynurenines in Huntington’s disease and stroke-induced brain damage

Stone, T. W., Forrest, C. M., Stoy, N. S., & Darlington, L. G. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0676-8 · Cited by 53

Crystal Structure-Based Selective Targeting of the Pyridoxal 5′-Phosphate Dependent Enzyme Kynurenine Aminotransferase II for Cognitive Enhancement

Rossi, F., Casazza, V., Garavaglia, S., Sathyasaikumar, K. V., Schwarcz, R. M., Kojima, S., Okuwaki, K., Ono, S.-I., Kajii, Y., & Rizzi, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100464k · Cited by 53

Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery

Forrest, C. M., Mackay, G., Oxford, L., Millar, K., Darlington, L. G., Higgins, M. J., & Stone, T. W. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07414.x · Cited by 53

Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: A pharmacological analysis

Linderholm, K. R., Andersson, A., Olsson, S. K., Olsson, E., Snodgrass, R., Engberg, G., & Erhardt, S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.09.003 · Cited by 51

l-Cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II

Kocki, T., Luchowski, P., Luchowska, E., Wielosz, M., Turski, W. A., & Urbańska, E. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00579-2 · Cited by 50

Exposure to Kynurenic Acid During Adolescence Produces Memory Deficits in Adulthood

Akagbosu, C., Evans, G. C., Gulick, D., Suckow, R. F., & Bucci, D. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq151 · Cited by 50

Lack of Modulation of Nicotinic Acetylcholine Alpha-7 Receptor Currents by Kynurenic Acid in Adult Hippocampal Interneurons

Dobelis, P., Staley, K. J., & Cooper, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041108 · Cited by 49

Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to l-kynurenine

Stążka, J., Luchowski, P., Wielosz, M., Kleinrok, Z., & Urbańska, E. M. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01943-x · Cited by 46

Selective increases in the cytokine, TNFα, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs

Paterson, G., Ohashi, Y., Reynolds, G. P., Pratt, J. A., & MORRIS, B. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106062025 · Cited by 41

α7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation

Ren, K., Thinschmidt, J. S., Liu, J., Ai, L., Papke, R. L., King, M. A., Hughes, J. A., & Meyer, E. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.023 · Cited by 41

Synthesis and biological effects of some kynurenic acid analogs

Nagy, K., Plangár, I., Tuka, B., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.029 · Cited by 37

Dynamic regulation of NMDAR function in the adult brain by the stress hormone corticosterone

Tse, Y. C., Bagot, R. C., & Wong, T. P. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00009 · Cited by 37

Behavioral and electrophysiological correlates of the quinolinic acid rat model of Huntington's disease in rats

Popoli, P., Pèzzola, A., Domenici, M. R., Sagratella, S., Diana, G., Caporali, M. G., Bronzetti, E., Vega, J., & de Carolis, A. S. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90109-0 · Cited by 36

Age Dependency of Inhibition of α7 Nicotinic Receptors and Tonically Active N-Methyl-d-aspartate Receptors by Endogenously Produced Kynurenic Acid in the Brain

Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., Kajii, Y., Schwarcz, R. M., & Albuquerque, E. X. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177386 · Cited by 36

Social isolation rearing in rats alters plasma tryptophan metabolism and is reversed by sub-chronic clozapine treatment

Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.021 · Cited by 36

Endogenous activation of nAChRs and NMDA receptors contributes to the excitability of CA1 stratum radiatum interneurons in rat hippocampal slices: Effects of kynurenic acid

Alkondon, M., Pereira, E. F. R., & Albuquerque, E. X. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.004 · Cited by 35

Kynurenic acid protects against the homo-cysteine-induced impairment of endothelial cells

Wejksza, K., Rzeski, W., & Turski, W. A. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70130-6 · Cited by 35

Intravenous administration of L-kynurenine to rhesus monkeys: Effect on quinolinate and kynurenate levels in serum and cerebrospinal fluid

Jauch, D., Sethy, V. H., Weick, B. G., et al. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90171-x · Cited by 34

ChemInform Abstract: Synthesis and Biochemical Evaluation of N‐(4‐Phenylthiazol‐2‐yl)benzenesulfonamides as High‐Affinity Inhibitors of Kynurenine 3‐Hydroxylase.

Roever, S., Cesura, A. M., Huguenin, P. N., Kettler, R., & Szente, A. (1998) · ChemInform · doi:10.1002/chin.199820156 · Cited by 34

Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice

Miura, H., Ando, Y., Noda, Y., Isobe, K., & Ozaki, N. (2011) · Stress · doi:10.3109/10253890.2010.541539 · Cited by 32

Effects of striatal excitotoxicity on Huntingtin-like immunoreactivity

Tatter, S. B., Galpern, W. R., Hoogeveen, A. T., et al. (1995) · Neuroreport · doi:10.1097/00001756-199505300-00013 · Cited by 31

Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats

Batterman, K. V., & Bucci, D. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.014 · Cited by 30

Uptake of 3-hydroxykynurenine measured in rat brain slices and in a neuronal cell line

Eastman, C. L., Guilarte, T. R., & Lever, J. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)90883-b · Cited by 29

Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?

Müller, N., & Dursun, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110364268 · Cited by 29

Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid

Stążka, J., Luchowski, P., & Urbańska, E. M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.04.048 · Cited by 27

Discovery of hydroxamate bioisosteres as KAT II inhibitors with improved oral bioavailability and pharmacokinetics

Henderson, J. L., Sawant‐Basak, A., Tuttle, J. B., Dounay, A. B., McAllister, L. A., Pandit, J., Rong, S., Hou, X., Bechle, B. M., Kim, J.-Y., et al. (2012) · MedChemComm · doi:10.1039/c2md20166f · Cited by 23

CHANGES IN CORTICAL KYNURENIC ACID BI-DIRECTIONALLY MODULATE PREFRONTAL GLUTAMATE LEVELS AS ASSESSED BY MICRODIALYSIS AND RAPID ELECTROCHEMISTRY

Konradsson-Geuken, Å., Wu, H., Gash, C., Alexander, K. S., Campbell, A., Sozeri, Y., Pellicciari, R., Schwarcz, R., & Bruno, J. P. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.052 · Cited by 15

Chapter 2 Neurochemistry of cognition: serotonergic and adrenergic mechanisms

Ph, R., & Benoît, M. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)88002-x · Cited by 11

Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects

Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158

The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates

Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945

Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis

Jenkins, T., Nguyen, J., Polglaze, K., & Bertrand, P. (2016) · Nutrients · doi:10.3390/nu8010056 · Cited by 904

NAD+ in Brain Aging and Neurodegenerative Disorders

Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790

Kynurenine pathway metabolism and the microbiota-gut-brain axis

Kennedy, P. J., Cryan, J. F., Dinan, T. G., & Clarke, G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.002 · Cited by 724